Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP08.03 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
EP08.03-006 - Survival After Radical Treatment of Oligometastatic Non-small Cell Lung Cancer: A Multicenter Analysis
Presenter: Isabelle Opitz- Abstract
Loading...
-
+
P1.14 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Preclinical
-
+
P1.14-01 - Transcriptomic Analysis of Malignant Pleural Mesothelioma (MPM) Reveals Insights for Basic Research and Preclinical Testing
Presenter: Alexander Laure- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- 14:45 - 15:45
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Noboru Yamamoto, Paul J Van Houtte
-
+
MA10.10 - Discussant
15:27 - 15:37 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
Session Moderator
16:52 - 17:00 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
Session Moderator
16:52 - 17:00 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.01 - Session Introduction
16:00 - 16:01 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
OA12.02 - Session Introduction
16:01 - 16:02 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.03 - Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
16:02 - 16:12 | Presenter: Jonathan Goldman
- Abstract
Loading... -
+
OA12.04 - Efficacy of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer after Chemo-Immunotherapy: A Phase 2 Trial.
16:12 - 16:22 | Presenter: Dwight H Owen
- Abstract
Loading... -
+
OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
16:22 - 16:32 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Presenter: Charles M Rudin
- Abstract
Loading... -
+
OA12.07 - Discussant
16:42 - 16:52 | Presenter: Virginie Westeel
- Abstract
Loading... -
+
OA12.08 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
